share_log

Intelligent Bio Solutions | 8-K: Current report

Intelligent Bio Solutions | 8-K: Current report

Intelligent Bio Solutions | 8-K:重大事件
美股sec公告 ·  05/03 16:35
Moomoo AI 已提取核心信息
Intelligent Bio Solutions Inc., a Delaware-incorporated company listed on The Nasdaq Stock Market under the trading symbol INBS, has filed a Form 8-K with the United States Securities and Exchange Commission on April 29, 2024. The report indicates that as a result of recent common stock issuances and the exercise of outstanding warrants, the total number of outstanding shares of the company's common stock has reached 3,117,049 as of the close of business on the reported date. The company, identified as an emerging growth company, has not elected to use the extended transition period for complying with new or revised financial accounting standards. The filing, signed by Spiro Sakiris on May 3, 2024, also includes an interactive data file for the cover page within the Inline XBRL document.
Intelligent Bio Solutions Inc., a Delaware-incorporated company listed on The Nasdaq Stock Market under the trading symbol INBS, has filed a Form 8-K with the United States Securities and Exchange Commission on April 29, 2024. The report indicates that as a result of recent common stock issuances and the exercise of outstanding warrants, the total number of outstanding shares of the company's common stock has reached 3,117,049 as of the close of business on the reported date. The company, identified as an emerging growth company, has not elected to use the extended transition period for complying with new or revised financial accounting standards. The filing, signed by Spiro Sakiris on May 3, 2024, also includes an interactive data file for the cover page within the Inline XBRL document.
Intelligent Bio Solutions Inc. 是一家在纳斯达克股票市场上市的特拉华州注册公司,交易代码为INBS,已于2024年4月29日向美国证券交易委员会提交了8-K表格。报告显示,由于最近发行普通股和行使未偿认股权证,截至报告日营业结束时,公司普通股的已发行总股数已达到3,117,049股。该公司被认定为新兴成长型公司,并未选择使用延长的过渡期来遵守新的或修订的财务会计准则。该文件由斯皮罗·萨基里斯于2024年5月3日签署,还包括Inline XBRL文档封面页的交互式数据文件。
Intelligent Bio Solutions Inc. 是一家在纳斯达克股票市场上市的特拉华州注册公司,交易代码为INBS,已于2024年4月29日向美国证券交易委员会提交了8-K表格。报告显示,由于最近发行普通股和行使未偿认股权证,截至报告日营业结束时,公司普通股的已发行总股数已达到3,117,049股。该公司被认定为新兴成长型公司,并未选择使用延长的过渡期来遵守新的或修订的财务会计准则。该文件由斯皮罗·萨基里斯于2024年5月3日签署,还包括Inline XBRL文档封面页的交互式数据文件。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息